ClinicalTrials.Veeva

Menu

Neuroaxial Blokade and Blood Pressure

Rigshospitalet logo

Rigshospitalet

Status

Unknown

Conditions

Hypovolemia

Treatments

Procedure: Stroke volume optimization

Study type

Interventional

Funder types

Other

Identifiers

NCT00435422
Neuroaxial blokade and BP

Details and patient eligibility

About

The effect of individualized fluid optimization during neuroaxial blockade has not been evaluated. The investigators evaluated if if Stroke decrease 15 min after activation of neuroaxial blockade and whether SV could be optimized to pre activation values.

Full description

The purpose of this study is to evaluate SV maximization with aid of the LiDCO system which is a minimal invasive technique only requiring a venous and arterial line. We thereby attempt to cover the specific individual fluid deficit induced by neuroaxial blockade.

Enrollment

16 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Neuroaxial blockade (thoracic)

Exclusion criteria

  • Weight below 40 kg
  • Lithium therapy
  • Type I diabetes or type II requiring insulin

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

Trial contacts and locations

1

Loading...

Central trial contact

Morten Bundgaard-Nielsen, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems